Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received an average rating of “Buy” from the nine analysts that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $16.08.

CCRN has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Cross Country Healthcare from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. BidaskClub downgraded shares of Cross Country Healthcare from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. Benchmark Co. restated a “buy” rating and issued a $17.00 target price (down previously from $18.00) on shares of Cross Country Healthcare in a research note on Wednesday, August 9th. Finally, UBS AG restated a “buy” rating and issued a $15.00 target price (down previously from $16.50) on shares of Cross Country Healthcare in a research note on Wednesday, June 14th.

In related news, insider William J. Grubbs sold 49,113 shares of Cross Country Healthcare stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $12.16, for a total value of $597,214.08. Following the completion of the transaction, the insider now directly owns 395,188 shares of the company’s stock, valued at $4,805,486.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 4.20% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. LS Investment Advisors LLC raised its holdings in shares of Cross Country Healthcare by 484.5% in the first quarter. LS Investment Advisors LLC now owns 7,184 shares of the business services provider’s stock valued at $103,000 after buying an additional 5,955 shares during the last quarter. Globeflex Capital L P bought a new position in shares of Cross Country Healthcare in the first quarter valued at about $104,000. Mason Street Advisors LLC raised its holdings in shares of Cross Country Healthcare by 6.9% in the first quarter. Mason Street Advisors LLC now owns 7,713 shares of the business services provider’s stock valued at $111,000 after buying an additional 499 shares during the last quarter. BNP Paribas Arbitrage SA raised its holdings in shares of Cross Country Healthcare by 57.7% in the second quarter. BNP Paribas Arbitrage SA now owns 9,998 shares of the business services provider’s stock valued at $129,000 after buying an additional 3,660 shares during the last quarter. Finally, Louisiana State Employees Retirement System raised its holdings in shares of Cross Country Healthcare by 0.8% in the first quarter. Louisiana State Employees Retirement System now owns 13,400 shares of the business services provider’s stock valued at $192,000 after buying an additional 100 shares during the last quarter. 95.52% of the stock is owned by institutional investors and hedge funds.

Cross Country Healthcare (NASDAQ:CCRN) traded up 0.49% during mid-day trading on Wednesday, hitting $14.23. 165,142 shares of the company were exchanged. Cross Country Healthcare has a 12-month low of $10.88 and a 12-month high of $16.38. The stock’s 50 day moving average is $12.46 and its 200-day moving average is $12.87. The company has a market cap of $519.31 million, a price-to-earnings ratio of 52.51 and a beta of 0.85.

Cross Country Healthcare (NASDAQ:CCRN) last issued its earnings results on Wednesday, August 2nd. The business services provider reported $0.16 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.09 by $0.07. Cross Country Healthcare had a net margin of 1.06% and a return on equity of 12.78%. The company had revenue of $209.31 million for the quarter, compared to the consensus estimate of $209.92 million. During the same quarter in the previous year, the company earned $0.16 EPS. The firm’s revenue for the quarter was up 4.9% compared to the same quarter last year. Equities research analysts predict that Cross Country Healthcare will post $0.61 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/09/30/cross-country-healthcare-inc-ccrn-receives-16-08-consensus-pt-from-analysts.html.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Stock Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related stocks with our FREE daily email newsletter.